Primary |
Pain |
14.3% |
Back Pain |
12.9% |
Hypertension |
9.8% |
Ill-defined Disorder |
9.8% |
Arthritis |
8.0% |
Osteoarthritis |
7.7% |
Arthralgia |
6.6% |
Rheumatoid Arthritis |
4.9% |
Diabetes Mellitus |
3.8% |
Abdominal Pain |
3.5% |
Neck Pain |
3.5% |
Inflammation |
2.1% |
Cardiac Disorder |
1.7% |
Essential Hypertension |
1.7% |
Musculoskeletal Pain |
1.7% |
Pharyngolaryngeal Pain |
1.7% |
Prophylaxis |
1.7% |
Tendonitis |
1.7% |
Aortic Valve Replacement |
1.4% |
Depression |
1.4% |
|
Drug Hypersensitivity |
19.6% |
Weight Decreased |
8.7% |
Vomiting |
7.6% |
Hypersensitivity |
5.4% |
Deafness |
4.3% |
Drug Interaction |
4.3% |
Gastrointestinal Haemorrhage |
4.3% |
Pain |
4.3% |
Toxic Epidermal Necrolysis |
4.3% |
Urticaria |
4.3% |
Deafness Unilateral |
3.3% |
Death |
3.3% |
Drug Ineffective |
3.3% |
Factor Viii Inhibition |
3.3% |
Gastrointestinal Disorder |
3.3% |
Gastrooesophageal Reflux Disease |
3.3% |
Interstitial Lung Disease |
3.3% |
Lower Gastrointestinal Haemorrhage |
3.3% |
Malaise |
3.3% |
Melaena |
3.3% |
|
Secondary |
Drug Use For Unknown Indication |
18.4% |
Product Used For Unknown Indication |
10.2% |
Pain |
8.4% |
Foetal Exposure During Pregnancy |
7.7% |
Intervertebral Disc Protrusion |
7.4% |
Hypertension |
6.3% |
Osteoarthritis |
5.6% |
Back Pain |
5.3% |
Ill-defined Disorder |
4.6% |
Arthritis |
4.3% |
Arthralgia |
3.4% |
Factor Viii Deficiency |
2.9% |
Ankylosing Spondylitis |
2.4% |
Rheumatoid Arthritis |
2.4% |
Blood Cholesterol Increased |
2.1% |
Cardiac Disorder |
2.1% |
Depression |
1.9% |
Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
Prophylaxis |
1.6% |
Sciatica |
1.5% |
|
Drug Hypersensitivity |
9.7% |
Factor Viii Inhibition |
9.7% |
Interstitial Lung Disease |
7.8% |
Toxic Epidermal Necrolysis |
7.8% |
Pyrexia |
6.8% |
Rash |
5.8% |
Renal Failure |
5.8% |
White Blood Cell Count Increased |
5.8% |
Myocardial Infarction |
4.9% |
Spondylitis |
4.9% |
Shock |
3.9% |
Thrombocytopenia |
3.9% |
Anal Fissure |
2.9% |
Death |
2.9% |
Drug Ineffective |
2.9% |
Haemoglobin Decreased |
2.9% |
Haemolytic Anaemia |
2.9% |
Malaise |
2.9% |
Oedema Peripheral |
2.9% |
Rectal Haemorrhage |
2.9% |
|
Concomitant |
Rheumatoid Arthritis |
20.1% |
Product Used For Unknown Indication |
12.3% |
Drug Use For Unknown Indication |
9.7% |
Arthritis |
6.5% |
Pain |
6.0% |
Hypertension |
5.3% |
Osteoporosis |
4.8% |
Depression |
4.2% |
Multiple Myeloma |
4.0% |
Psoriatic Arthropathy |
3.5% |
Hiv Infection |
3.4% |
Bone Disorder |
2.8% |
Chronic Obstructive Pulmonary Disease |
2.8% |
Ankylosing Spondylitis |
2.7% |
Back Pain |
2.5% |
Inflammation |
2.2% |
Arthralgia |
1.9% |
Hormone Replacement Therapy |
1.8% |
Angina Pectoris |
1.7% |
Arrhythmia |
1.7% |
|
Vomiting |
11.0% |
Psoriasis |
8.8% |
Vitamin B12 Deficiency |
8.8% |
Viral Infection |
7.1% |
Urticaria |
5.5% |
Weight Increased |
5.5% |
Tremor |
4.9% |
Vision Blurred |
4.9% |
Weight Decreased |
4.9% |
Wheezing |
4.9% |
Rhabdomyolysis |
4.4% |
Toxicity To Various Agents |
3.8% |
Vertebral Wedging |
3.8% |
Osteoporosis |
3.3% |
Pain |
3.3% |
Urine Output Decreased |
3.3% |
White Blood Cell Count Increased |
3.3% |
Breast Cancer Female |
2.7% |
Nausea |
2.7% |
Tooth Extraction |
2.7% |
|
Interacting |
Intervertebral Disc Protrusion |
39.2% |
Product Used For Unknown Indication |
19.6% |
Prophylaxis Against Gastrointestinal Ulcer |
9.3% |
Pain |
7.2% |
Back Pain |
6.2% |
Sciatica |
6.2% |
Ill-defined Disorder |
4.1% |
Rheumatoid Arthritis |
4.1% |
Drug Use For Unknown Indication |
2.1% |
Pharyngitis |
2.1% |
|
Rash |
20.0% |
Drug Exposure During Pregnancy |
13.3% |
Lower Gastrointestinal Haemorrhage |
13.3% |
Renal Failure Acute |
13.3% |
Abortion Spontaneous |
6.7% |
Drug Interaction |
6.7% |
Erythema Infectiosum |
6.7% |
Intentional Overdose |
6.7% |
Oedema Mucosal |
6.7% |
Pregnancy |
6.7% |
|